Pancreatic cancer risk variant ABO rs505922 in patients with cholangiocarcinoma

doi:10.3748/wjg.v17.i41.4640

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 41

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2985)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

381

HTML

2348

Figures (1-1)

133

Tables (1-1)

123

Sum=2985

Nov 7, 2011 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letters To The Editor

World J Gastroenterol. Nov 7, 2011; 17(41): 4640-4642
Published online Nov 7, 2011. doi: 10.3748/wjg.v17.i41.4640

Open in New Tab Full Size Figure Download Figure

Figure 1 Statistical power as a function of the effect size (odds ratio) in the cholangiocarcinoma cohort (black) and in extra- and intrahepatic cholangiocarcinoma subgroups (dark grey and grey, respectively) (α set at 0. 05). CCA: Cholangiocarcinoma.

Citation: Krawczyk M, Mihalache F, Höblinger A, Acalovschi M, Lammert F, Zimmer V. Pancreatic cancer risk variant ABO rs505922 in patients with cholangiocarcinoma. World J Gastroenterol 2011; 17(41): 4640-4642
URL: https://www.wjgnet.com/1007-9327/full/v17/i41/4640.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i41.4640